Barry Hoffmaster argues that the moral cost of commodifying kidneys for transplantation must be calculated before the health care costs can be considered.
Aviva Goldberg suggests that while payment may increase the number of living kidney providers, this benefit may not outweigh the risks associated with commodification of the human body.
Syd Johnson calls for bioethicists to better serve the public interest by cultivating substantive and critical discussion of ethically complex issues.
Barry Hoffmaster offers us a meditation on Impact Ethics.


